David Daikh is a Rheumatology/Immunology physician affiliated with Oregon Health & Science University. OpenAlex indexes 113 publications with 8,978 citations (h-index 29); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Portland, OR 972393011
Telephone
503-494-8637Registry record last updated 17 Jul 2019.
Clinical trials
- Stress Management for Patients With Multiple Sclerosis
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
47.2%Folate Analog Metabolic Inhibitor18.1%Methotrexate100%Part D≥19 patientsTNF inhibitor16.9%Humira(Cf) Pen38%Enbrel Sureclick33%Humira Pen15%Simponi14%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
22.7%Corticosteroid22.7%Prednisone100%Part D≥25 patientsAntiparasitic
16.9%Antimalarial16.9%Hydroxychloroquine Sulfate100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rheumatoid arthritis: Evolving recognition of a common disease
Best Practice & Research Clinical Rheumatology
2022 - European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
Annals of the Rheumatic Diseases
2021 - Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities
Annals of the Rheumatic Diseases
2020 - 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Annals of the Rheumatic Diseases
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”